Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases (2017)
- Authors:
- USP affiliated authors: LACCHINI, RICCARDO - EERP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidades: EERP; FMRP
- DOI: 10.1016/j.niox.2016.08.004
- Subjects: ÓXIDO NÍTRICO; POLIMORFISMO; FARMACOGENÉTICA; ENDOTÉLIO VASCULAR
- Keywords: Endothelial nitric oxide synthase; Genetic polymorphisms; Haplotypes; Nitric oxide; NOS3 gene; Pharmacogenetics
- Language: Inglês
- Imprenta:
- Publisher place: Maryland Heights
- Date published: 2017
- Source:
- Título do periódico: Nitric Oxide
- ISSN: 1089-8603
- Volume/Número/Paginação/Ano: v. 63, p. 39-51, 2017
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: publisher-specific-oa
-
ABNT
OLIVEIRA-PAULA, Gustavo Henrique e LACCHINI, Riccardo e TANUS-SANTOS, José Eduardo. Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases. Nitric Oxide, v. 63, p. 39-51, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.niox.2016.08.004. Acesso em: 18 abr. 2024. -
APA
Oliveira-Paula, G. H., Lacchini, R., & Tanus-Santos, J. E. (2017). Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases. Nitric Oxide, 63, 39-51. doi:10.1016/j.niox.2016.08.004 -
NLM
Oliveira-Paula GH, Lacchini R, Tanus-Santos JE. Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases [Internet]. Nitric Oxide. 2017 ; 63 39-51.[citado 2024 abr. 18 ] Available from: https://doi.org/10.1016/j.niox.2016.08.004 -
Vancouver
Oliveira-Paula GH, Lacchini R, Tanus-Santos JE. Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases [Internet]. Nitric Oxide. 2017 ; 63 39-51.[citado 2024 abr. 18 ] Available from: https://doi.org/10.1016/j.niox.2016.08.004 - Interethnic differences in the distribution of matrix metalloproteinases genetic polymorphisms are consistent with interethnic differences in disease prevalence
- Increased activity of MMP-2 in hypertensive obese children is associated with hypoadiponectinemia
- Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease
- Endothelial nitric oxide synthase: from biochemistry and gene structure to clinical implications of NOS3 polymorphisms
- The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity
- Endotélio e genética
- Genetic variants in matrix metalloproteinase-9 gene modify metalloproteinase-9 levels in black subjects
- Association of polymorphisms of endothelial nitric oxide synthase (eNOS) gene with the risk of primary open angle glaucoma in a Brazilian population
- Functional matrix metalloproteinase (MMP)-9 genetic variants modify the effects of hemodialysis on circulating MMP-9 levels
- Pharmacogenetics of erectile dysfunction: navigating into uncharted waters
Informações sobre o DOI: 10.1016/j.niox.2016.08.004 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
